Maxim Group Reiterates Buy Rating, $20 PT on Viking Therapeutic (VKTX)
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy reiterated a Buy rating and $20.00 price target on Viking Therapeutic (NASDAQ: VKTX) following positive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
